Microsphere Liposomes are commonly used as carriers for drugs to improve solubility, bioavailability, and targeting, while providing controlled release.
The global Microsphere Liposomes market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Microsphere Liposomes Industry Forecast” looks at past sales and reviews total world Microsphere Liposomes sales in 2023, providing a comprehensive analysis by region and market sector of projected Microsphere Liposomes sales for 2024 through 2030. With Microsphere Liposomes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microsphere Liposomes industry.
This Insight Report provides a comprehensive analysis of the global Microsphere Liposomes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microsphere Liposomes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microsphere Liposomes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microsphere Liposomes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microsphere Liposomes.
United States market for Microsphere Liposomes is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Microsphere Liposomes is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Microsphere Liposomes is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Microsphere Liposomes players cover Gilead Sciences Ltd, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Microsphere Liposomes market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Monolayer Lipid Microsphere Formulation
Multilayer Lipid Microsphere Formulation
Others
Segmentation by Application:
Pharmaceutical
Biomedical
Cosmetics
Foodstuffs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Gilead Sciences Ltd
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Lipoid
Evonik
NOF Corporation
FormuMax Scientific, Inc.
Nanopartz Inc.
Beijing Sihuan Pharmaceutical
Nanjing Sike Medicine
Key Questions Addressed in this Report
What is the 10-year outlook for the global Microsphere Liposomes market?
What factors are driving Microsphere Liposomes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Microsphere Liposomes market opportunities vary by end market size?
How does Microsphere Liposomes break out by Type, by Application?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Microsphere Liposomes Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Microsphere Liposomes by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Microsphere Liposomes by Country/Region, 2019, 2023 & 2030 2.2 Microsphere Liposomes Segment by Type 2.2.1 Monolayer Lipid Microsphere Formulation 2.2.2 Multilayer Lipid Microsphere Formulation 2.2.3 Others 2.3 Microsphere Liposomes Sales by Type 2.3.1 Global Microsphere Liposomes Sales Market Share by Type (2019-2024) 2.3.2 Global Microsphere Liposomes Revenue and Market Share by Type (2019-2024) 2.3.3 Global Microsphere Liposomes Sale Price by Type (2019-2024) 2.4 Microsphere Liposomes Segment by Application 2.4.1 Pharmaceutical 2.4.2 Biomedical 2.4.3 Cosmetics 2.4.4 Foodstuffs 2.4.5 Others 2.5 Microsphere Liposomes Sales by Application 2.5.1 Global Microsphere Liposomes Sale Market Share by Application (2019-2024) 2.5.2 Global Microsphere Liposomes Revenue and Market Share by Application (2019-2024) 2.5.3 Global Microsphere Liposomes Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Microsphere Liposomes Breakdown Data by Company 3.1.1 Global Microsphere Liposomes Annual Sales by Company (2019-2024) 3.1.2 Global Microsphere Liposomes Sales Market Share by Company (2019-2024) 3.2 Global Microsphere Liposomes Annual Revenue by Company (2019-2024) 3.2.1 Global Microsphere Liposomes Revenue by Company (2019-2024) 3.2.2 Global Microsphere Liposomes Revenue Market Share by Company (2019-2024) 3.3 Global Microsphere Liposomes Sale Price by Company 3.4 Key Manufacturers Microsphere Liposomes Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Microsphere Liposomes Product Location Distribution 3.4.2 Players Microsphere Liposomes Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Microsphere Liposomes by Geographic Region 4.1 World Historic Microsphere Liposomes Market Size by Geographic Region (2019-2024) 4.1.1 Global Microsphere Liposomes Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Microsphere Liposomes Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Microsphere Liposomes Market Size by Country/Region (2019-2024) 4.2.1 Global Microsphere Liposomes Annual Sales by Country/Region (2019-2024) 4.2.2 Global Microsphere Liposomes Annual Revenue by Country/Region (2019-2024) 4.3 Americas Microsphere Liposomes Sales Growth 4.4 APAC Microsphere Liposomes Sales Growth 4.5 Europe Microsphere Liposomes Sales Growth 4.6 Middle East & Africa Microsphere Liposomes Sales Growth 5 Americas 5.1 Americas Microsphere Liposomes Sales by Country 5.1.1 Americas Microsphere Liposomes Sales by Country (2019-2024) 5.1.2 Americas Microsphere Liposomes Revenue by Country (2019-2024) 5.2 Americas Microsphere Liposomes Sales by Type (2019-2024) 5.3 Americas Microsphere Liposomes Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Microsphere Liposomes Sales by Region 6.1.1 APAC Microsphere Liposomes Sales by Region (2019-2024) 6.1.2 APAC Microsphere Liposomes Revenue by Region (2019-2024) 6.2 APAC Microsphere Liposomes Sales by Type (2019-2024) 6.3 APAC Microsphere Liposomes Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Microsphere Liposomes by Country 7.1.1 Europe Microsphere Liposomes Sales by Country (2019-2024) 7.1.2 Europe Microsphere Liposomes Revenue by Country (2019-2024) 7.2 Europe Microsphere Liposomes Sales by Type (2019-2024) 7.3 Europe Microsphere Liposomes Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Microsphere Liposomes by Country 8.1.1 Middle East & Africa Microsphere Liposomes Sales by Country (2019-2024) 8.1.2 Middle East & Africa Microsphere Liposomes Revenue by Country (2019-2024) 8.2 Middle East & Africa Microsphere Liposomes Sales by Type (2019-2024) 8.3 Middle East & Africa Microsphere Liposomes Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Microsphere Liposomes 10.3 Manufacturing Process Analysis of Microsphere Liposomes 10.4 Industry Chain Structure of Microsphere Liposomes 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Microsphere Liposomes Distributors 11.3 Microsphere Liposomes Customer 12 World Forecast Review for Microsphere Liposomes by Geographic Region 12.1 Global Microsphere Liposomes Market Size Forecast by Region 12.1.1 Global Microsphere Liposomes Forecast by Region (2025-2030) 12.1.2 Global Microsphere Liposomes Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Microsphere Liposomes Forecast by Type (2025-2030) 12.7 Global Microsphere Liposomes Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Gilead Sciences Ltd 13.1.1 Gilead Sciences Ltd Company Information 13.1.2 Gilead Sciences Ltd Microsphere Liposomes Product Portfolios and Specifications 13.1.3 Gilead Sciences Ltd Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Gilead Sciences Ltd Main Business Overview 13.1.5 Gilead Sciences Ltd Latest Developments 13.2 Pacira 13.2.1 Pacira Company Information 13.2.2 Pacira Microsphere Liposomes Product Portfolios and Specifications 13.2.3 Pacira Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Pacira Main Business Overview 13.2.5 Pacira Latest Developments 13.3 Sun Pharmaceutical 13.3.1 Sun Pharmaceutical Company Information 13.3.2 Sun Pharmaceutical Microsphere Liposomes Product Portfolios and Specifications 13.3.3 Sun Pharmaceutical Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Sun Pharmaceutical Main Business Overview 13.3.5 Sun Pharmaceutical Latest Developments 13.4 Johnson & Johnson 13.4.1 Johnson & Johnson Company Information 13.4.2 Johnson & Johnson Microsphere Liposomes Product Portfolios and Specifications 13.4.3 Johnson & Johnson Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Johnson & Johnson Main Business Overview 13.4.5 Johnson & Johnson Latest Developments 13.5 Luye Pharma 13.5.1 Luye Pharma Company Information 13.5.2 Luye Pharma Microsphere Liposomes Product Portfolios and Specifications 13.5.3 Luye Pharma Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Luye Pharma Main Business Overview 13.5.5 Luye Pharma Latest Developments 13.6 Sigma-Tau 13.6.1 Sigma-Tau Company Information 13.6.2 Sigma-Tau Microsphere Liposomes Product Portfolios and Specifications 13.6.3 Sigma-Tau Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Sigma-Tau Main Business Overview 13.6.5 Sigma-Tau Latest Developments 13.7 Ipsen (Onivyde) 13.7.1 Ipsen (Onivyde) Company Information 13.7.2 Ipsen (Onivyde) Microsphere Liposomes Product Portfolios and Specifications 13.7.3 Ipsen (Onivyde) Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Ipsen (Onivyde) Main Business Overview 13.7.5 Ipsen (Onivyde) Latest Developments 13.8 CSPC 13.8.1 CSPC Company Information 13.8.2 CSPC Microsphere Liposomes Product Portfolios and Specifications 13.8.3 CSPC Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 CSPC Main Business Overview 13.8.5 CSPC Latest Developments 13.9 Teva Pharmaceutical 13.9.1 Teva Pharmaceutical Company Information 13.9.2 Teva Pharmaceutical Microsphere Liposomes Product Portfolios and Specifications 13.9.3 Teva Pharmaceutical Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Teva Pharmaceutical Main Business Overview 13.9.5 Teva Pharmaceutical Latest Developments 13.10 Novartis 13.10.1 Novartis Company Information 13.10.2 Novartis Microsphere Liposomes Product Portfolios and Specifications 13.10.3 Novartis Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Novartis Main Business Overview 13.10.5 Novartis Latest Developments 13.11 Fudan-Zhangjiang 13.11.1 Fudan-Zhangjiang Company Information 13.11.2 Fudan-Zhangjiang Microsphere Liposomes Product Portfolios and Specifications 13.11.3 Fudan-Zhangjiang Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Fudan-Zhangjiang Main Business Overview 13.11.5 Fudan-Zhangjiang Latest Developments 13.12 Lipoid 13.12.1 Lipoid Company Information 13.12.2 Lipoid Microsphere Liposomes Product Portfolios and Specifications 13.12.3 Lipoid Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 Lipoid Main Business Overview 13.12.5 Lipoid Latest Developments 13.13 Evonik 13.13.1 Evonik Company Information 13.13.2 Evonik Microsphere Liposomes Product Portfolios and Specifications 13.13.3 Evonik Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 Evonik Main Business Overview 13.13.5 Evonik Latest Developments 13.14 NOF Corporation 13.14.1 NOF Corporation Company Information 13.14.2 NOF Corporation Microsphere Liposomes Product Portfolios and Specifications 13.14.3 NOF Corporation Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 NOF Corporation Main Business Overview 13.14.5 NOF Corporation Latest Developments 13.15 FormuMax Scientific, Inc. 13.15.1 FormuMax Scientific, Inc. Company Information 13.15.2 FormuMax Scientific, Inc. Microsphere Liposomes Product Portfolios and Specifications 13.15.3 FormuMax Scientific, Inc. Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.15.4 FormuMax Scientific, Inc. Main Business Overview 13.15.5 FormuMax Scientific, Inc. Latest Developments 13.16 Nanopartz Inc. 13.16.1 Nanopartz Inc. Company Information 13.16.2 Nanopartz Inc. Microsphere Liposomes Product Portfolios and Specifications 13.16.3 Nanopartz Inc. Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.16.4 Nanopartz Inc. Main Business Overview 13.16.5 Nanopartz Inc. Latest Developments 13.17 Beijing Sihuan Pharmaceutical 13.17.1 Beijing Sihuan Pharmaceutical Company Information 13.17.2 Beijing Sihuan Pharmaceutical Microsphere Liposomes Product Portfolios and Specifications 13.17.3 Beijing Sihuan Pharmaceutical Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.17.4 Beijing Sihuan Pharmaceutical Main Business Overview 13.17.5 Beijing Sihuan Pharmaceutical Latest Developments 13.18 Nanjing Sike Medicine 13.18.1 Nanjing Sike Medicine Company Information 13.18.2 Nanjing Sike Medicine Microsphere Liposomes Product Portfolios and Specifications 13.18.3 Nanjing Sike Medicine Microsphere Liposomes Sales, Revenue, Price and Gross Margin (2019-2024) 13.18.4 Nanjing Sike Medicine Main Business Overview 13.18.5 Nanjing Sike Medicine Latest Developments 14 Research Findings and Conclusion